<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
TAK
Takeda
$
()


  • Takeda, Astellas Pharma and Sumitomo Mitsui to establish joint venture company

    4/22/2024 - 05:21am
  • FDA approves subcutaneous administration of Takeda's ENTYVI in Crohn's disease

    4/18/2024 - 19:03pm
  • Takeda selects eight U.S. non-profit organizations as grant recipients

    4/8/2024 - 08:05am
  • Japan approves Takeda's ADZYNMA to treat 'ultra-rare' disorder cTTP

    3/26/2024 - 08:09am
  • Scilex announces agreement with Takeda to resolve patent infringement lawsuit

    3/20/2024 - 09:06am
  • Takeda announces FDA approval of supplemental indication for Iclusig

    3/19/2024 - 12:23pm
  • Takeda leukemia treatment granted accelerated approval by FDA

    3/19/2024 - 11:31am
  • Centogene extends partnership with Takeda

    3/19/2024 - 06:32am
  • Protagonist closes rusfertide license, collaboration agreement with Takeda

    3/18/2024 - 07:10am
  • Takeda announces results from Phase 2 study of mezagitamab as antibody for ITP

    3/13/2024 - 08:12am
  • Takeda price target raised by 60c at JPMorgan

    3/8/2024 - 11:16am
  • Takeda, Biological E. Limited collaborate to accelerate access to Dengue vaccine

    2/27/2024 - 05:37am
  • FDA approvesTakeda's Eohilia for eosinophilic esophagitis treatment

    2/12/2024 - 08:05am
  • Takeda to rapidly initiate the first global Phase 3 trials of TAK-861

    2/8/2024 - 18:02pm
  • Takeda announces CFO Costa Saroukos to leave, Milano Furuta to succeed

    2/1/2024 - 05:43am
dynamic_feed Breaking News